Novo Nordisk says Victoza helps lower heart risks
COPENHAGEN (Reuters) - Novo Nordisk said on Friday the results from a trial showed that its Victoza diabetes drug significantly reduced the risks of major adverse cardiovascular events.
Source: Reuters: Health - Category: Consumer Health News Tags: healthNews Source Type: news